Psychotropic drugs, HERG, and the heart.
Hancox
J C
JC
Witchel
H J
HJ
D014150:Antipsychotic Agents / Q000009:adverse effects; D027682:Cation Transport Proteins; D004268:DNA-Binding Proteins; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; D006801:Humans; D008133:Long QT Syndrome / Q000235:genetics*; D015221:Potassium Channels / Q000187:drug effects*; D024642:Potassium Channels, Voltage-Gated; D011619:Psychotropic Drugs / Q000009:adverse effects*; D013881:Thioridazine / Q000009:adverse effects; D015534:Trans-Activators; D000071230:Transcriptional Regulator ERG
D014150:Antipsychotic Agents; D027682:Cation Transport Proteins; D004268:DNA-Binding Proteins; C072312:ERG protein, human; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; C000606913:KCNH2 protein, human; C092509:KCNH6 protein, human; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D011619:Psychotropic Drugs; D015534:Trans-Activators; D000071230:Transcriptional Regulator ERG; D013881:Thioridazine